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Available online 29 March 2014AbstractSuccessful anterior cruciate ligament (ACL) reconstruction with tendon graft requires extensive tendon-to-bone healing in the bone tunnels
and progressive graft ligamentization for biological, structural, and functional recovery of the ACL. Improvement in graft-to-bone healing is
crucial for facilitating early, aggressive rehabilitation after surgery to ensure an early return to pre-injury activity levels. The use of various
biomaterials for enhancing the healing of tendon grafts in bone tunnels has been developed. With the biological enhancement of tendon-to-bone
healing, biological fixation of the tendon graft in the tunnel can be achieved in ACL reconstruction.
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An anterior cruciate ligament (ACL) injury is a common
knee injury among people of all ages, particularly athletes. The
healing potential of a ruptured ACL is often extremely poor. In
most cases, spontaneous ACL healing is insufficient. Recon-
struction of the ACL is often required and has become a routine
arthroscopic surgical procedure. The use of the semitendinosus
and gracilis tendons in ACL reconstruction has become popular
in recent years. However, successful ACL reconstruction with
tendon grafting requires effective healing and integration of the
tendon graft into the bone tunnels of the femur and tibia.
The native tendon or ligament insertion into bone is a highly
specialized tissue that functions to transfer complexmechanical
loads from soft tissue to bone. Ligaments have either direct or
indirect insertion sites. The ACL inserts into bone through a
direct insertion site that forms a transition zone from the tendon
to the bone. This transition zone consists of the tendon, non-
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X, and XI, are found in the fibrocartilage of the insertion site,
with collagen X playing a fundamental role in maintaining the
interface between mineralized and demineralized fibro-
cartilage.1,2 Indirect insertion sites are composed of a type of
collagen fibre known as Sharpey fibre that forms oblique to the
long axis of the bone. The Sharpey fibres anchor the ligament to
the bone, giving it mechanical strength.
The structure and composition of a healthy direct ACL
insertion site is not reproduced after ligament reconstruction
with tendon grafts. Studies have shown that, instead of
regenerating the four zones of the native direct insertion site,
the graft heals with an interposed layer of fibrovascular scar
tissue at the graftetunnel interface.3e6 Tendon-to-bone
healing in a bone tunnel develops through bone ingrowth
into the tissue of the fibrovascular interface that initially
forms between the tendon and the bone. Progressive miner-
alization of the interface tissue occurs, with subsequent bone
ingrowth into the outer tendon and the incorporation of the
tendon graft into the surrounding bone. Progressive re-
establishment of the continuity of the collagen fibres of the
tendon and the bone results in the reformation of the ten-
donebone junction.e Society. Published by Elsevier (Singapore) Pte Ltd. This is an open access
c-nd/4.0/).
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initially consists of a woven bone formation that is fairly
weak. The interface between the tendon graft and the bone
tunnel contains three distinct histological zones that resemble
a fibrous tendon insertion and the weak connection between
the graft and bone tunnel may fail following ACL
reconstruction.7e13 The firm attachment of the tendon graft to
the bone is a critical factor in facilitating early aggressive
rehabilitation and thus a speedier return to sports and work
activities. Biological fixation initiates the graft to bone tunnel
healing to achieve graft fixation in ACL reconstruction. Bio-
logical fixation techniques include intraoperative intervention
with biological agents or postoperative extracorporeal inter-
vention to enhance the graftebone healing to achieve the ef-
fect of graft fixation and healing.
Many materials have been used to augment or enhance the
healing of the tendon to the bone. Several studies have
investigated strategies to improve bone ingrowth into tendon
grafts. Autografts consisting of autologous ACL rupture tis-
sues have been used to enhance tendon-to-bone healing.14e16
Treatments using osteoinductive factors, such as demineral-
ized bone matrix and enamel matrix derivatives have enhanced
tendon-to-bone healing in animal studies.17e19 Other osteo-
conductive materials may also improve tendon healing in the
bone tunnel. Osteoconductive agents, such as calcium phos-
phate (CaP), hydroxyapatite, nanohydroxyapatite-based
boneegraft substitute, tricalcium phosphate, brushite CaP
cement, and CaP cement, have been used to improve bone
formation around the tendon grafts.20e27 With the biological
enhancement of tendonebone healing, biological fixation of
the tendon graft in the tunnel in the ACL reconstruction can be
achieved.
Osteoclast-manipulation agents, such as alendronate and
osteoprotegerin, have been used to inhibit osteoclast activity and
promote bone formation at the tendonebone interface.28,29
Stem cells are undifferentiated cells that, when directed by
appropriate developmental signalling, can differentiate into a
wide range of specialized cell types, thus representing a po-
tential repair system for an equally wide range of tissues. Pre-
vious studies have evaluated the effects of stem cells from
various sources on tendon-to-bone healing, including bone
marrow stromal cells, mesenchymal stem cells, synovium-
derived stem cells, and ACL-derived CD34þ cell sheets.30e37
Histological and biomechanical studies have shown that
growth factors, such as platelet-derived growth factor-BB,
vascular endothelial growth factor, platelet-rich plasma
(PRP), transforming growth factor, bone morphogenetic pro-
tein (BMP)-2, and granulocyte colony-stimulating factor, may
improve tendon-to-bone healing.38e45 Indirect stimulation
using low-intensity pulsed ultrasound, hyperbaric oxygen, or
shock waves has been used for extracorporeal stimulation to
enhance tendon-to-bone healing.46e48
Simvastatin, an inhibitor of the competitive 3-hydroxy-3-
methyl-glutaryl coenzyme A reductase, has been shown to
exert an anabolic effect on bone formation both in vitro and
in vivo by activating the expression of BMP-2.49 Using a rabbit
model, a previous study showed that the local administrationof low-dose simvastatin-conjugated gelatin hydrogel promoted
tendon-to-bone healing during the early phase following ACL
reconstruction through the effect of simvastatin on angiogen-
esis and osteogenesis, but did not affect the long-term
biomechanical properties of the reconstruction.49
Periosteum, periosteal progenitor cell hydrogel, or perios-
teal progenitor cell sheet have been applied to enhance tendon-
to-bone healing to achieve the effect of biological fixation.
The periosteum consists of multipotent mesodermal cells and
has been shown to contain chondroprogenitor and osteopro-
genitor cells, which have the capacity to form cartilage and
bone, respectively.50e53 In a rabbit model of ACL recon-
struction, the effects of using periosteum-enveloped tendon
graft in the bone tunnel for better graftebone healing was
achieved.54,55
Periosteal progenitor cells (PPC) have the potential to
differentiate to osteoprogenitor and chondroprogenitor cells.
PPCs can be used to enhance tendon-to-bone healing through
the formation of interface fibrocartilage. A novel injectable
hydrogel containing PPCs and BMP-2 was evaluated in a
rabbit model of tendon-to-bone healing. Histological analysis
showed interface fibrocartilage and newly formed bone.
Biomechanical testing revealed a significantly higher
maximum pullout strength and stiffness in the experimental
group. The tendonebone interface undergoes a gradual
remodelling process during healing. BMP-2 and PPCs are
powerful enhancers of tendon-to-bone healing in the rabbit
model.56e62 In the ACL reconstruction model, ACL recon-
struction using the flexor digitorum longus tendon was per-
formed in rabbits. Histological analysis of the tendonebone
interface in the bone tunnels showed fibrocartilage formation
in the tendonebone junction. Biomechanical testing revealed a
significantly higher maximal pullout load at all time points.
The PPCeBMP-2 hydrogel was a powerful enhancer of
tendon-to-bone healing through the de novo formation of
fibrocartilage.63,64
Bioengineered PPC sheets were evaluated for the
enhancement of tendon-to-bone healing in the extra-articular
bone tunnel using a rabbit model. The tendon graft was
wrapped in PPC sheets and inserted into the bone tunnel of the
tibia. Histological staining of the tendonebone junction
showed that the PPC sheets enhanced collagen and glycos-
aminoglycan deposition in the newly formed fibrocartilage.
Mature fibrocartilage and dense collagen fibres formed at the
tendonebone interface and more chondrocytes had formed at
the interface of the animals treated with the PPC sheets.
Treatment using the PPC sheets resulted in the formation of
fibrocartilage and bone regeneration around the tendon graft.65
The bioengineered PPC sheets represent a novel, feasible
therapeutic strategy for enhancing tendon-to-bone healing
following ACL reconstruction.
Clinical application of biological agents for enhancement
of graft fixation and healing
The effects of periosteum, nanohydroxyapatite-based bone
graft substitute, platelet concentrate (PC), and CaP on tendon-
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reconstruction surgery (Table 1).PeriosteumIn a case-series study, we evaluated single-bundle ACL
reconstruction with periosteum-enveloped hamstring tendon
graft. From 2000 to 2005, four-strand periosteum-enveloped
hamstring tendon grafts were used for single-bundle ACL
reconstruction in 312 patients who underwent at least a 2-year
follow-up. The clinical follow-up assessments included the
Lysholm knee score, the International Knee Documentation
Committee (IKDC) score, arthrometric laxity testing (MED-
metric KT-1000 Arthrometer, San Diego, CA, USA), and thigh
muscle assessment. Radiographs were also used to assess the
widening of the bone tunnels of the femur and tibia.
The mean follow-up period was 4.6 years (range 2e7
years). The median Lysholm knee score prior to and after
surgery was 56 points (range 40e70 points) and 95 points
(range 60e100 points), respectively. After ACL reconstruc-
tion, 85% of the patients returned to moderate or strenuous
activity. Grade 2 or higher ligament laxity was observed inTable 1
Biological fixation agents and techniques for enhancement of tendonebone
healing in anterior cruciate ligament reconstruction.
Material Enhancement agent Clinical
application
and effect
Autograft Periosteum þ/þ
Autologous rupture tissue 
Osteoinductive
factors
Demineralized bone matrix 
Enamel matrix derivative 
Osteoclast manipulation
agents
Alendronate 
Osteoprotegerin 
Growth factors Platelet-rich plasma þ/
Bone morphogenetic protein 
Transforming growth factor 
Bone morphogenetic protein 2 
Granulocyte colony-stimulating
factor

Collagen-platelet composite 
Platelet concentrate þ
Bioactive materials Calcium phosphate þ/þ
Calcium phosphate cement þ/þ
Nanohydroxyapatite-based bone
graft substitute
þ/þ
Tricalcium phosphate 
Brushite calcium phosphate cement 
Stem cells Bone marrow stromal cells 
Mesenchymal stem cells 
Synovium-derived stem cell 
Periosteum progenitor cell hydrogel 
Periosteum progenitor cell sheet 
Anterior cruciate ligament-derived
CD34þ cell sheets

Indirect stimulation Low-intensity pulsed ultrasound 
Hyperbaric oxygen 
Shock wave 
þ/þ ¼ clinical application with positive effect; þ/ ¼ clinical application
without significant effect;  ¼ no clinical application.5.1% of the patients based on the anterior drawer test and
6.1% of the patients had a positive pivot shift. Complete range
of motion was achieved in 88% of the patients and 93% of the
patients had an IKDC score within or near the normal range.
Satisfactory results were achieved using the periosteum-
enveloped hamstring tendon graft in the single-bundle ACL
reconstruction and minimal tunnel widening was observed.
Bone tunnel enlargement >1 mm was identified in 5.4% of the
femoral tunnels and in 6.1% of tibial tunnels, which is less
than that reported in previous studies that used comparable
fixation.66,67Nanohydroxyapatite-based bone-graft substituteA prospective study was designed to clinically and radio-
logically evaluate the efficacy of nanohydroxyapatite bone-
based grafts for facilitating healing after hamstring tendon
ACL reconstruction. To the best of our knowledge, this is the
first study to assess the efficacy of such a bone substitute in
humans. Forty men with chronic ACL rupture underwent
surgical reconstruction with four-strand semitendinosus and
gracilis tendon autograft using a single-bundle technique. The
Lysholm, Tegner, IKDC, and arthrometric-laxity clinical as-
sessments showed no significant difference between the two
groups. Radiological analysis at the short or midterm follow-
up examinations showed significantly greater graft strength,
improved graftebone interface healing, and reduced bone
oedema in the patients who received the nanohydroxyapatite
treatment. However, no significant long-term difference was
observed between the two groups. Thus the use of the nano-
hydroxyapatite bone substitute did not provide significant
clinical improvement in knee stability or patient satisfaction.27Hybridizing calcium phosphateA novel technique has been proposed to improve tendon-to-
bone healing by hybridizing CaP to the tendon graft using an
alternating soaking process. Sixty-four patients with unilateral
ACL rupture underwent arthroscopically-assisted single-
bundle ACL reconstruction using a four-strand semitendinosus
tendon or four-strand semitendinosus and gracilis tendon
autograft, EndoButton femoral fixation (Acufex Microsur-
gical, Mansfield, MA, USA), and screw washer tibial fixation.
Patients were randomly selected to undergo the CaP or the
conventional reconstruction using the closed envelope method
and a transtibial tunnel approach. In the CaP group, the tendon
graft was hybridized with the CaP at both ends of the graft.
One surgeon performed all the reconstructions and was blin-
ded to the type of graft used. The data regarding age at sur-
gery, sex, injury to surgery interval, and associated meniscal
injuries were similar between the two groups. The follow-up
assessments for all patients used the same postoperative
protocol.
The KT-1000 arthrometry data indicated that the average
anterior tibial translation was significantly lower in the CaP
group at the 1- and 2-year follow-up evaluations compared
with that of the conventional reconstruction group. Two years
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CaP group than in the conventional reconstruction group. One
year after surgery, the CaP-hybridized tendon grafts showed
less enlargement of the anteroposterior diameter of the main
joint aperture site of the bone tunnel compared with that of the
conventional reconstruction group. The results of the pivot-
shift test, the IKDC assessment, the Tegner score, the in-
tensity of the tendon graft in magnetic resonance imaging
(MRI), and arthroscopic assessments were not significantly
different between the two groups at both the 1- and 2-year
follow-up examinations. The use of the CaP-hybridized
tendon graft improved anterior knee stability and the
Lysholm score at the 2-year follow-up. Less enlargement in
both tunnels was also observed at the 1-year follow-up in the
patients who received the CaP-hybridized graft compared with
that in the patients who underwent conventional single-bundle
ACL reconstruction.25Platelet concentrateA prospective clinical study evaluated the use of PC for
accelerating the healing process following ACL reconstruc-
tion. Patients requiring ACL reconstruction were randomly
assigned to control, PC, bone plugs (BP), or combination PC
and BP study groups. Maturation of the graft was evaluated at
the femoral tunnel by using MRI maturation criteria based on
a low-intensity signal, the absence of an osteoligamentous
interface, and no widening of the femoral tunnel. Three
months after surgery, no significant difference in MRI matu-
ration was observed among the groups. Six months after the
operation, 78% of the patients in the control group showed a
low-intensity signal, whereas the low-intensity signal was
present in 100% of the PC patients. No statistical difference in
the osteoligamentous interface was observed between the
various groups. Tunnel widening had occurred in 11% of the
BP patients and 41% of the control patients, whereas no
significant widening was observed among the other groups.
The use of the PC enhanced graft maturation based on MRI
signal intensity, but showed no significant effect on the
osteoligamentous interface or the widening of the bone
tunnel.15Platelet-rich plasmaIn a prospective clinical study of the use of PRP to enhance
tendon-to-bone healing following ACL reconstruction, 40
patients were sequentially enrolled in Group A, Group B,
Group C, or Group D. Group A received no PRP and Group B
received PRP in the femoral tunnel at the end of the operation.
Group C received PRP in the femoral tunnel at the end of the
operation and intra-articularly at 2 weeks and 4 weeks after the
operation. Group D received thrombin-activated PRP in the
femoral tunnel. Three months after the operation, all patients
underwent MRI of the knee to evaluate the signal intensity of
the fibrous interzone in the femoral tunnels. No significant
difference in signal intensity was observed among the various
study groups.43Conclusion
Improvement in graft-to-bone healing is crucial to ensure
early aggressive rehabilitation and an early return to pre-injury
levels of physical activity. Tendon-to-bone healing with bio-
logical agents in a bone tunnel has been applied to achieve the
effects of biological fixation in ACL reconstruciton. Various
biological agents such as growth factors and stem cells,
including transforming growth factor b, BMP-2, granulocyte
colony-stimulating factor, mesenchymal stem cells, ACL-
derived CD34þ cell sheets, synovium-derived stem cells,
PPC hydrogel, and PPC sheet, can play critical roles in tissue
repair in both in vitro and in vivo studies. However, critical
obstacles remain regarding the clinical application of these
materials, such as dose determination, delivery technique,
maintenance of the effect in the tunnel, and cost effectiveness.
A simple, more reliable technique is required.
The application of certain biological agents to the ten-
donebone interface and the bone tunnel have been evaluated
in animal studies. These include the use of CaP, brushite CaP
cement, demineralized bone matrix, magnesium-based bone
adhesive, nanohydroxyapatite-based bone graft substitute,
simvastatin-conjugated gelatin hydrogel, and enamel matrix
derivative. However, the lack of extensive clinical evaluation
of these materials limits their application.
The effects of periosteum, PC, PRP, CaP, and nano-
hydroxyapatite bone-base bone graft substitutes on tendon-to-
bone healing following ACL reconstruction should be exten-
sively evaluated clinically to clarify the effects of biological
fixation. Indirect stimulation postoperatively using hyperbaric
oxygen, low-intensity pulsed ultrasound, or shock waves have
also been applied, but the effects of these techniques on
tendon-to-bone healing also lack extensive clinical
assessments.
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